IRadimed Corporation Overview
Pro stress-test →IRadimed develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. The company serves hospitals, acute care facilities, and outpatient imaging centers.
Strategic Profile
Pro stress-test →The company highlighted its 17 consecutive quarters of record revenue and cited sustained financial health and strong stock performance as drivers of the recognition. The device maintains Iradimed's unique position as the world's only provider of non-magnetic MRI infusion pumps since 2005. This replacement strategy is a key factor in IRADIMED's projection of breaking through the $100 million revenue run rate in 2026. Domestic pump device revenue is expected to grow from an estimated $28 million in 2025 to nearly $50 million in 2026, driven by these upgrades.
Competitive Landscape
Pro stress-test →IRadimed maintains a unique market position as the sole manufacturer of non-magnetic MRI-compatible infusion pumps since 2005. The specialized nature of MRI-safe medical devices creates high barriers to entry, with few direct competitors in this niche. The company competes primarily with traditional IV pump manufacturers on functionality and safety integration, but its MRI compatibility focus provides differentiation in the critical imaging/acute care segment.
Industry Context
IRadimed Corporation operates in Medical Devices - MRI-Compatible Equipment & Infusion Therapy Systems.
Key facts
Founded: 1992 · Headquarters: Winter Springs, United States · Employees: null · Revenue: $82.5M-$83.5M (FY 2025 guidance) · Market cap: $1.17B